## AIZ: Assurant, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.46 indicates fundamental undervaluation. Quality metrics strong (ROE 15%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($214.02)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Federated Hermes Inc. Has $53.99 Million Stake in Assurant, Inc. $AIZ**
- Source: MarketBeat | 20251209T100816 | Somewhat-Bullish | Relevance: 99%
-  Federated Hermes Inc. has reduced its stake in Assurant, Inc. by 17.9% during the second quarter, now holding 273,391 shares valued at approximately $53.99 million. Despite this, other institutional investors have increased their positions in Assurant, and Wall Street analysts generally maintain a "Moderate Buy" rating with a consensus price target of $250.00. The company recently increased its quarterly dividend and reported solid financial performance, including a return on equity of 18.61%.

**2. Assurant, Inc. $AIZ Shares Sold by First Trust Advisors LP**
- Source: MarketBeat | 20251206T093406 | Somewhat-Bullish | Relevance: 99%
-  First Trust Advisors LP reduced its stake in Assurant, Inc. by 5.6% in the second quarter, selling 33,143 shares and now holding 556,449 shares valued at approximately $109.9 million. The company also announced an increase in its quarterly dividend to $0.88 per share, and CEO Keith Demmings sold 13,725 shares of his holdings. Analysts currently rate Assurant with a "Moderate Buy" consensus.

**3. How Assurant Inc. (AIZ) Affects Rotational Strategy Timing**
- Source: Stock Traders Daily | 20251207T182400 | Neutral | Relevance: 98%
-  This article analyzes Assurant Inc. (AIZ) using AI models, suggesting weak near-term sentiment and a high-risk-reward short setup. It outlines three trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis for AIZ. The analysis indicates potential downside targets and provides entry and exit points for various trading approaches.

**4. Assurant, Inc. $AIZ Holdings Raised by Arrowstreet Capital Limited Partnership**
- Source: MarketBeat | 20251209T083451 | Bullish | Relevance: 98%
- Arrowstreet Capital Limited Partnership significantly increased its holdings in Assurant, Inc. (NYSE:AIZ) by 458.4% in the second quarter, now owning 79,845 shares valued at $15.77 million. Several other hedge funds also adjusted their stakes in the financial services provider, which recently raised its quarterly dividend to $0.88 per share. The company currently holds an average analyst rating of "Moderate Buy" with an average target price of $250.00.

**5. CW Advisors LLC Has $2.23 Million Holdings in Assurant, Inc. $AIZ**
- Source: MarketBeat | 20251207T230757 | Somewhat-Bullish | Relevance: 95%
-  CW Advisors LLC significantly increased its stake in Assurant, Inc. (NYSE:AIZ) by 82.4% in the second quarter, now holding 11,308 shares valued at approximately $2.23 million. Assurant recently raised its quarterly dividend to $0.88, leading to an annualized payout of $3.52 and a yield of about 1.6%. Despite some insider selling by CEO Keith Demmings, institutional investors maintain a strong ownership of 92.65% in the company, and analysts have a "Moderate Buy" consensus rating with a $250 price target.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Keefe, Bruyette | $254 | $248 | +2% |
| 2025-11-17 | Morgan Stanley | $248 | $232 | +7% |
| 2025-11-10 | UBS | $257 | $255 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Keefe, Bruyette | main | Outperform |
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |
| 2025-11-10 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.10M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-2.0%)
- Bank Of New York Mel: 10.0% (+23.7%)
- Blackrock Inc.: 7.9% (-0.4%)
- T. Rowe Price Invest: 7.7% (-3.5%)
- State Street Corpora: 5.4% (-3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +3%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.46 suggests fair value with growth premium. Balance sheet: strong liquidity (11492000000.0x). Institutional flow bearish (9 selling vs 1 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $11.2B |
| Beta | 0.57 |
| 52W Range | $174.97 - $232.02 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.46 |
| Forward P/E | 10.7 |
| Current P/E | 11.4 |
| YoY Growth | 6.8% |
| EPS Direction | RISING |

### Technicals

MRS_20 stable at -3.7% (minimal 5-day change). Below STRENGTH zone by 7.7pp (needs >4.0% for momentum thesis). Underperforming sector by 3.2pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.08x) but short-term weakness (below SMA20). MACD histogram bearish (-0.95), momentum weakening. RSI neutral at 48.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.66% (CS: 26) | Weak |
| RSI_14 | 48.3 | Neutral |
| MACD Histogram | -0.95 | Bearish |
| vs SMA20 | 0.983x | Below |
| vs SMA50 | 1.012x | Above |
| vs SMA200 | 1.079x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $221.76
- **Stop Loss:** $214.02 (3.5% risk)
- **Target:** $237.24 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 129
- **Position Value:** $28,607.04
- **Portfolio %:** 28.61%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-02-10 (Est: $5.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.28 | $5.73 | +34.0% |
| 2025Q2 | $4.45 | $5.10 | +14.5% |
| 2025Q1 | $2.78 | $3.39 | +22.1% |
| 2024Q4 | $4.13 | $4.79 | +15.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*